Heart failure & cardiomyopathies

Combination of an implantable defibrillator multi-sensor heart failure index and an apnea index for the prediction of atrial high-rate events

EuropacePublished Prospective cohort study

Authors' conclusion

In HF patients, the occurrence of AHRE is independently associated with the ICD-measured IN-alert HF state and RDI ≥ 30 episodes/h. The coexistence of these two conditions occurs rarely but is associated with a very high rate of AHRE occurrence.

Study context

Population
Heart failure (HF) patients with ICDconsecutive HF patients with ICD
Participants
411 patients
Exposure
IN-alert HF state and severe sleep apnoea (SA) vs neither
Outcome
Daily AHRE burden of ≥5 min, ≥6 h and ≥23 h
Follow-up
Median 26 months
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

AHRE
Hazard ratio (95% CI)P value
RDI ≥ 30 episodes/hAHRE ≥5 min/day only
1.55(1.11–2.16)
P = 0.001
IN-alert HF state · atrial high-rate events (AHRE) ≥5 min/day; independently associated
HR 2.17; P < 0.01
IN-alert HF state · AHRE ≥23 h/day; independently associated
HR 3.43; P < 0.01
AHRE burden ≥5 min/day
139 (34%) patients
AHRE burden ≥6 h/day
89 (22%) patients
AHRE burden ≥23 h/day
68 (17%) patients
Time IN-alert HF state, % of observation period
13%
Time with Respiratory Disturbance Index (RDI) ≥30 episodes/h, % of observation period
58%

Observational data: associations, not effects.

Further findings

AHRE rate with combined IN-alert HF state and RDI ≥30 episodes/h

Combination, % of follow-up period
6%
AHRE burden ≥5 min/day
28 events/100 patient-years
AHRE burden ≥23 h/day
22 events/100 patient-years

Original publication

Combination of an implantable defibrillator multi-sensor heart failure index and an apnea index for the prediction of atrial high-rate events. Europace. Published 7 March 2023. doi:10.1093/europace/euad052

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.